Evidence map›Paper›PMID 29808582›Full record

ArticlePhytochemical analysis : PCA2018

Dereplication of plant phenolics using a mass-spectrometry database independent method.

Ricardo M Borges, Rahil Taujale, Juliana Santana de Souza, Thaís de Andrade Bezerra, Eder Lana E Silva, Ronny Herzog, Francesca V Ponce, Jean-Luc Wolfender, Arthur S Edison

Abstract read
In one paragraph

Article in Phytochemical analysis : PCA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Targeted Isolation of Indole Alkaloids fromMolecules (Basel, Switzerland) · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ricardo M BorgesComplex Carbohydrate Research Centre (CCRC), Departments of Genetics and Biochemistry, Institute of Bioinformatics, University of Georgia, Athens, GA, USA.ORCID http://orcid.org/0000-0002-7662-6734
Rahil TaujaleComplex Carbohydrate Research Centre (CCRC), Departments of Genetics and Biochemistry, Institute of Bioinformatics, University of Georgia, Athens, GA, USA.
Juliana Santana de SouzaNatural Product Research Institute Walter Mors (IPPN), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Thaís de Andrade BezerraNatural Product Research Institute Walter Mors (IPPN), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Eder Lana E SilvaNatural Product Research Institute Walter Mors (IPPN), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
Ronny HerzogLipotype GmbH, Dresden, Germany.
Francesca V PonceComplex Carbohydrate Research Centre (CCRC), Departments of Genetics and Biochemistry, Institute of Bioinformatics, University of Georgia, Athens, GA, USA.
Jean-Luc WolfenderSchool of Pharmaceutical Sciences, EPGL, University of Geneva, University of Lausanne, CMU, Geneva, Switzerland.
Arthur S EdisonComplex Carbohydrate Research Centre (CCRC), Departments of Genetics and Biochemistry, Institute of Bioinformatics, University of Georgia, Athens, GA, USA.

Funding

TR&D1: Stem Cell and Induced Pluripotent Stem Cell Resources (Pages 116-134)P41GM103490 · NIGMS · UNIVERSITY OF GEORGIA · PI PIERCE, J. MICHAEL · 2012 to 2018
$13.7M
Glycoscience Training ProgramT32GM107004 · NIGMS · UNIVERSITY OF GEORGIA · PI AMSTER, I JONATHAN, HALTIWANGER, ROBERT S. · 2014 to 2021
$1.3M
Orbitrap Fusion Tribrid Mass SpectrometerS10OD018530 · OD · UNIVERSITY OF GEORGIA · PI AZADI, PARASTOO · 2014 to 2014
$750k
National Institutes of Health (NIH)-funded Research Resource for Biomedical Glycomics P41GM10349010NIGMS NIH HHS P41 GM103490NIGMS NIH HHS T32 GM107004NIH HHS S10 OD018530NIH HHS T32-GM107004
6 · The paper itself

Abstract

introductionDereplication, an approach to sidestep the efforts involved in the isolation of known compounds, is generally accepted as being the first stage of novel discoveries in natural product research. It is based on metabolite profiling analysis of complex natural extracts.

objectiveTo present the application of LipidXplorer for automatic targeted dereplication of phenolics in plant crude extracts based on direct infusion high-resolution tandem mass spectrometry data. MATERIAL AND

methodsLipidXplorer uses a user-defined molecular fragmentation query language (MFQL) to search for specific characteristic fragmentation patterns in large data sets and highlight the corresponding metabolites. To this end, MFQL files were written to dereplicate common phenolics occurring in plant extracts. Complementary MFQL files were used for validation purposes.

resultsNew MFQL files with molecular formula restrictions for common classes of phenolic natural products were generated for the metabolite profiling of different representative crude plant extracts. This method was evaluated against an open-source software for mass-spectrometry data processing (MZMine®) and against manual annotation based on published data.

conclusionThe targeted LipidXplorer method implemented using common phenolic fragmentation patterns, was found to be able to annotate more phenolics than MZMine® that is based on automated queries on the available databases. Additionally, screening for ascarosides, natural products with unrelated structures to plant phenolics collected from the nematode Caenorhabditis elegans, demonstrated the specificity of this method by cross-testing both groups of chemicals in both plants and nematodes.

Indexed as

AnimalsBiological ProductsCaenorhabditis elegansDatabases, FactualLipid MetabolismMetabolomicsMolecular StructurePhenolsPlant ExtractsSoftwareTandem Mass SpectrometryBiological ProductsPhenolsPlant ExtractsdereplicationDI-ESI-MSLipidXplorerphenolic natural products

Identifiers

PMID29808582
PMCPMC8962509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.